Pharmaceutical Manufacturing Handbook: Production and

556 BIODEGRADABLE NANOPARTICLES
48. Qi , L. , Xu , Z. , Jiang , X. , Hu , C. , and Zou , X. ( 2004 ), Preparation and antibacterial activity
of chitosan nanoparticles , Carbohydr. Res. , 339 ( 16 ), 2693 – 2700 .
49. Liu , C. G. , Desai , K. G. , Chen , X. G. , and Park , H. J. ( 2005 ), Preparation and characterization
of nanoparticles containing trypsin based on hydrophobically modifi ed chitosan ,
J. Agric. Food Chem. , 53 ( 5 ), 1728 – 1733 .
50. Grenha , A. , Seijo , B. , and Remunan - Lopez , C. ( 2005 ), Microencapsulated chitosan
nanoparticles for lung protein delivery , Eur. J. Pharm. Sci. , 25 ( 4 – 5 ), 427 – 437 .
51. Enriquez de Salamanca , A. , Diebold , Y. , Calonge , M. , Garcia - Vazquez , C. , Callejo , S. ,
Vila , A. , and Alonso , M. J. ( 2006 ), Chitosan nanoparticles as a potential drug delivery
system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance , Invest.
Ophthalmol. Vis. Sci. , 47 ( 4 ), 1416 – 1425 .
52. Saito , H. , Wu , X. , Harris , M. , and Hoffman , A. ( 2003 ), Graft copolymers of poly(ethylene
glycol) (PEG) and chitosan , Macromol. Rapid Commun. , 18 ( 7 ), 547 – 550 .
53. Bernkop - Schnurch , A. ( 2000 ), Chitosan and its derivatives: Potential excipients for
peroral peptide delivery systems , Int. J. Pharm. , 194 ( 1 ), 1 – 13 .
54. Hyung Park , J. , Kwon , S. , Lee , M. , Chung , H. , Kim , J. H. , Kim , Y. S. , Park , R. W. , Kim , I.
S. , Bong Seo , S. , Kwon , I. C. , and Young Jeong , S. ( 2006 ), Self - assembled nanoparticles
based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In
vivo biodistribution and anti - tumor activity , Biomaterials , 27 ( 1 ), 119 – 126 .
55. Mansouri , S. , Cuie , Y. , Winnik , F. , Shi , Q. , Lavigne , P. , Benderdour , M. , Beaumont , E. ,
and Fernandes , J. C. ( 2006 ), Characterization of folate - chitosan - DNA nanoparticles for
gene therapy , Biomaterials , 27 ( 9 ), 2060 – 2065 .
56. Yan , C. , Chen , D. , Gu , J. , and Qin , J. ( 2006 ), Nanoparticles of 5 - fl uorouracil (5 - FU)
loaded N - succinyl - chitosan (Suc - Chi) for cancer chemotherapy: Preparation, characterization
— in - vitro drug release and anti - tumour activity , J. Pharm. Pharmacol. , 58 ( 9 ),
1177 – 1181 .
57. Park , J. S. , Han , T. H. , Lee , K. Y. , Han , S. S. , Hwang , J. J. , Moon , D. H. , Kim , S. Y. , and
Cho , Y. W. ( 2006 ), N - acetyl histidine - conjugated glycol chitosan self - assembled nanoparticles
for intracytoplasmic delivery of drugs: Endocytosis, exocytosis and drug release ,
J. Controlled Release. , 115 ( 1 ), 37 – 45 .
58. Vandervoort , J. , and Ludwig , A. ( 2004 ), Preparation and evaluation of drug - loaded
gelatin nanoparticles for topical ophthalmic use , Eur. J. Pharm. Biopharm. , 57 ( 2 ),
251 – 261 .
59. Cascone , M. G. , Lazzeri , L. , Carmignani , C. , and Zhu , Z. ( 2002 ), Gelatin nanoparticles
produced by a simple W/O emulsion as delivery system for methotrexate , J. Mater. Sci.
Mater. Med. , 13 ( 5 ), 523 – 526 .
60. Lu , Z. , Yeh , T. K. , Tsai , M. , Au , J. L. , and Wientjes , M. G. ( 2004 ), Paclitaxel - loaded gelatin
nanoparticles for intravesical bladder cancer therapy , Clin. Cancer Res. , 10 ( 22 ),
7677 – 7684 .
61. Bajpai , A. K. , and Choubey , J. ( 2006 ), Design of gelatin nanoparticles as swelling
controlled delivery system for chloroquine phosphate , J. Mater. Sci. Mater. Med. , 17 ( 4 ),
345 – 358 .
62. Li , J. K. , Wang , N. , and Wu , X. S. ( 1997 ), A novel biodegradable system based on gelatin
nanoparticles and poly(lactic -co - glycolic acid) microspheres for protein and peptide
drug delivery , J. Pharm. Sci. , 86 ( 8 ), 891 – 895 .
63. Farrugia , C. A. , and Groves , M. J. ( 1999 ), The activity of unloaded gelatin nanoparticles
on murine melanoma B16 - F0 growth in vivo , Anticancer Res. , 19 ( 2A ), 1027 – 1031 .
64. Coester , C. , Kreuter , J. , von Briesen , H. , and Langer , K. ( 2000 ), Preparation of avidin -
labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA) ,
Int. J. Pharm. , 196 ( 2 ), 147 – 149 .